Page 9 - Sight Sciences News Today

MENLO PARK, Calif., July 20, 2023 -- Sight Sciences, Inc. , an eyecare technology company focused on developing and commercializing innovative technology intended to transform care and improve...

Sight Sciences Inc (NASDAQ: SGHT) released the six-month SAHARA randomized controlled trial comparing interventional eyelid procedures enabled by TearCare Technology to Restasis 

MENLO PARK, Calif., July 20, 2023 -- Sight Sciences, Inc. , an eyecare technology company focused on developing and commercializing innovative technology intended to transform care and improve...

Needham expects Glaukos Corp (NYSE: GKOS) to surpass expectations and raise outlook in Q2 FY23, fueled by rebounding iStent inject volumes post-2022 reimbursement-driven declines. An additional upside is expected from the accelerating iAccess and iPRIME launches.

Dozens of lobbyists and other K Street types have already maxed out to at least one candidate as of the filing deadline.

Citigroup lowered shares of Sight Sciences (NASDAQ:SGHT – Free Report) from a buy rating to a neutral rating in a research report sent to investors on Monday morning, Marketbeat reports. Citigroup currently has $9.00 price objective on the stock, down from their prior price objective of $15.00. Several other analysts also recently issued reports on […]

Citigroup cut shares of Sight Sciences (NASDAQ:SGHT – Free Report) from a buy rating to a neutral rating in a research report report published on Monday, MarketBeat Ratings reports. Citigroup currently has $9.00 price target on the stock, down from their prior price target of $15.00. A number of other research analysts have also issued […]

Sight Sciences Stock (NASDAQ: SGHT) stock price, news, charts, stock research, profile.